查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1827194

持續性周邊神經阻斷導管市場（按類型、引導技術、最終用戶和應用）—全球預測 2025-2032

Continuous Peripheral Nerve Block Catheter Market by Type, Guidance Technology, End User, Application - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，持續性周邊神經阻斷導管市場將成長至 6.3601 億美元，複合年成長率為 5.84%。

主要市場統計數據
基準年2024年 4.0361億美元
預計2025年 4.2618億美元
預測年份：2032年 6.3601億美元
複合年成長率（%） 5.84%

權威介紹，描述影響現代護理途徑中採用連續周邊神經阻斷導管的臨床、操作和採購演變

持續性周邊神經阻斷導管已成為手術全期疼痛管理的支柱，提供標靶鎮痛，減少全身性鴉片類藥物依賴，促進患者康復。過去幾年，臨床醫生和導管採購團隊仔細審查了導管的特性，例如導管設計、與引導技術的兼容性以及是否易於融入多模式鎮痛方案。這些因素改變了醫療機構評估和採用持續性神經阻斷解決方案的方式，使其關注點從單一手術的效用轉向更廣泛的手術全期路徑，強調縮短住院時間和改善功能恢復。

同時，臨床實務也越來越青睞那些符合術後恢復原則和門診手術照護模式的技術。這一趨勢推動了人們對設備性能的新期望，包括穩定的阻滯效果、允許早期活動的安全固定方法以及最大程度縮短手術時間的使用者介面。因此，製造商和臨床領導者正在建立更緊密的合作關係，以改善培訓、標準化通訊協定並檢驗真實世界的結果，從而創造一個技術創新和臨床證據共同影響購買和採用決策的環境。

因此，相關人員需要清晰的、基於證據的訊息，整合設備設計考量、引導技術影響以及最終用戶的觀點，為採購、臨床醫生教育和基於價值的採購策略提供指導。本報告旨在透過研究市場動態、臨床應用模式以及將持續周邊神經阻斷導管納入現代護理路徑的實用建議，提供切實可行的資訊。

全面評估臨床重點、影像引導的進步以及醫療保健服務的變化如何融合，以重新定義設備開發和採用的動態

由於臨床重點、技術融合和醫療服務模式的轉變，持續性周邊神經阻斷導管的市場格局正在發生重大變化。臨床上，鴉片類藥物節約策略和增強型恢復通訊協定的趨勢顯著，凸顯了可靠的局部麻醉技術的重要性。這些臨床需求推動了對能夠提供可預測鎮痛、支持早期物理治療並在適當情況下實現當天出院的設備的需求。

在技​​術方面，影像導引與導管設計的融合正在重塑手術工作流程。超音波引導已成為許多情況下的首選方法，它能夠可視化神經結構和局部麻醉劑，並提高阻斷的準確性和安全性。同時，製造商正在最佳化導管材質和固定系統，以降低移位和感染的風險，解決門診和住院環境中遇到的重要實踐障礙。這些技術進步與改進的培訓工具和基於模擬的教育相輔相成，進一步提高了臨床醫生的能力並加速了技術的普及。

醫療保健服務運作模式的轉變也影響著區域麻醉的採用軌跡。門診手術中心和協作護理模式的成長，使得能夠支援簡化手術流程並在不同環境下實現一致療效的設備成為重中之重。此外，不斷發展的報銷框架和品質指標，強調患者報告的療效並減少鴉片類藥物相關不利事件，正在獎勵醫院和診所優先考慮局部麻醉解決方案。總而言之，這些臨床、技術和營運因素正在重新調整整個價值鏈的開發重點和商業策略。

簡要分析2025年關稅變化對營運和採購的影響，以及供應鏈調整如何重塑商業策略

2025年關稅政策的訂定，為醫療設備產業的採購、供應鏈管理和商業策略帶來了新的複雜性。關稅調整影響了製造、分銷和採購管道的成本結構，迫使相關人員重新評估籌資策略和利潤預期。對於依賴跨境供應鏈的製造商而言，這些變化促使他們重新審視供應商合約、零件本地化和庫存緩衝，以降低風險敞口，增強對波動的進口關稅的抵禦能力。

醫院和門診中心正在透過收緊採購規範、延長競標週期以及優先採購不僅具有臨床價值而且總擁有成本可預測的設備來應對不斷變化的成本促進因素。在某些情況下，採購商正在探索其他供應商關係和合併採購協議，以抵消關稅帶來的額外成本。同時，小型專科診所對價格波動更為敏感，要求臨床醫生評估其手術流程和設備利用率，以便在不影響臨床品質的情況下，確保能夠進行局部麻醉手術。

為了應對這一變化，製造商和經銷商正在探索適應策略，例如將部分生產轉移至近岸外包，重新設計包裝以減輕關稅的影響，以及提供以培訓、保固和耗材管理為重點的配套服務模式。這些方法旨在保持競爭力，同時確保臨床醫生期望的臨床表現和支援服務。因此，關稅變化的淨影響不僅體現在財務方面，也體現在營運方面，這迫使相關人員進行務實的調整，以維持臨床可及性和長期的供應商夥伴關係。

綜合分段分析說明導管類型、影像和引導方式、臨床環境和程序應用如何共同決定採購和採用決策

細分洞察揭示了設備選擇和臨床部署如何因產品類型、引導技術、最終用戶偏好和應用而異，從而形成不同的採用路徑。在根據導管類型區分設備時，需要考慮的因素包括預期的手術用途以及臨床醫生對非刺激性導管（可簡化插入）和刺激性導管（可在插入過程中提供神經定位反饋）的偏好。這種區別會影響訓練要求和操作方案，因為在將電刺激確認神經接近度納入臨床實踐的情況下，刺激性導管可能更受青睞。

引導技術進一步提升了臨床工作流程和設備相容性。雖然在資源受限的環境中，盲法操作仍是主流，但神經刺激設備引導的方法可以透過確認運動反應來提高可靠性。相較之下，超音波引導正透過直接可視化解剖結構、提高阻滯精度並減少對二級立體定向方法的依賴，重新定義許多機構的實踐標準。因此，有助於超音波可視化的設備功能，例如迴聲導管設計和相容的插入套件，與優先考慮影像引導局部麻醉的團隊產生了強烈共鳴。

最終使用者環境也會影響採購和使用模式。門診手術中心優先考慮能夠簡化快速週轉、減少鴉片類藥物相關併發症並實現當天出院的設備。醫院通常會平衡更廣泛的病例組合，並投資於臨床醫生培訓和多學科路徑，以支援整形外科和產科服務中持續進行的導管插入計畫。專科診所可能專注於特定手術的工作流程，並採用符合特定臨床方案和患者吞吐量需求的設備。

應用為臨床醫生評估導管解決方案提供了終極視角。產科鎮痛需要適用於剖腹產和分娩鎮痛管理的設備和通訊協定，強調產婦活動能力和新生兒安全。整形外科手術對髖關節、膝關節和肩關節手術的需求各不相同，需要促進早期活動和復原的疼痛管理策略。手術室外的術後疼痛管理需要牢固的導管固定、感染控制措施以及清晰的門診方案，以支持家庭鎮痛。綜合起來，這些細分觀點凸顯了為什麼醫療設備組合和上市方案必須與臨床工作流程和特定場所的優先事項緊密結合。

細緻入微的區域觀點展示了美洲、歐洲、中東和非洲地區以及亞太地區在基礎設施、報銷和實踐方面的差異如何影響設備採用和商業化策略

區域動態對設備選擇、臨床訓練模式和分配策略有著強大的影響，這受到醫療基礎設施、報銷實踐和臨床實踐模式差異的影響。在美洲，臨床上強調加速復健、整形外科護理和產科護理，這促使人們對支持加速復健且安全的設備產生興趣。都市區三級醫療中心著重先進影像和多學科路徑的整合，而門診機構則優先考慮能夠最大程度縮短手術時間並支援當天出院的設備。

在歐洲、中東和非洲，醫療保健系統的差異導致了應用環境的差異。西歐資源豐富的醫院普遍廣泛採用超音波導引局部麻醉，並投資於基於模擬的臨床醫生培訓和標準化通訊協定。相較之下，中東和非洲部分地區由於影像設備和訓練有素的人員獲取管道的差異，仍在使用替代引導策略，並且對設備成本和耐用性更為敏感。這一廣大地區的分銷網路和監管途徑也各不相同，影響著製造商如何建構其市場准入和支援服務。

在亞太地區，手術量的快速成長和門診能力的不斷提升，推動了對高通量環境下可擴展解決方案的需求。與培訓計畫和學術中心的合作正在加速許多市場對影像引導手術的採用，而本地製造和供應結構往往會影響採購決策。在全部區域，相關人員正在應對全球臨床趨勢和特定地區的限制，促使製造商根據當地需求客製化其商業模式、教育推廣和服務，同時保持一致的設備性能標準。

從策略上評估產品創新、臨床醫生教育和服務模式如何定義區域麻醉的競爭優勢並影響採購選擇

持續性周邊神經阻斷導管領域的競爭動態主要集中在產品創新、臨床支援服務以及在實際應用中展現一致性能的能力。領先的製造商憑藉旨在降低移位和感染風險的導管材料和固定系統，以及簡化無菌技術和超音波整合的配件套件，在競爭中脫穎而出。同樣重要的是培訓計畫、模擬工具和臨床夥伴關係，這些能夠透過提高臨床醫生的信心和技術一致性來加速應用。

分銷和服務模式也有助於提升競爭優勢。提供整合設備、臨床醫生教育和上市後監測的捆綁式解決方案的公司，正日益受到尋求可預測結果和減輕營運負擔的醫院系統的青睞。與影像設備供應商、麻醉學會和學術中心的策略合作，可以提高知名度，並支持採用符合指南的實踐。在醫院重視服務連續性和快速設備補給的市場中，擁有敏捷供應鏈和本地化技術支援的供應商往往能夠蓬勃發展。

最後，透過註冊研究、觀察性研究和實際臨床合作等方式投入證據的公司，有助於檢驗真實世界的有效性，並為最佳實踐提供參考。此類臨床證據，加上強大的培訓和服務生態系統，能夠增強臨床醫生和採購委員會的信任，從而創造超越產品規格的永續競爭優勢。

為製造商和醫療保健領導者提供實用建議，使產品開發、臨床醫生培訓和供應策略與現實世界的臨床和營運重點保持一致

產業領導者可以果斷採取行動，抓住臨床和商業性機遇，將研發重點與最終用戶工作流程結合，並加強臨床支援能力。優先考慮能夠增強超音波可視化、安全固定和感染控制的導管功能，將解決臨床醫生最常提到的現實痛點。同時，投資擴充性的培訓計劃和模擬工具可以減少操作的差異性並加速應用，尤其是在要求操作人員一致性的醫院和門診中心。

在營運方面，製造商應考慮供應鏈策略，以降低關稅波動的影響，並提高對區域需求波動的應對力。選用方案包括：選擇性地將大批量生產外包，開發模組化包裝以降低關稅門檻，以及正式簽訂服務水準協議以確保及時補貨。商業團隊應強調捆綁式服務，將設備採購與臨床醫生培訓、保固支援和數據收集選項相結合，以量化手術結果和患者體驗。

從市場參與的角度來看，領導者應與整形外科和產科臨床領導者建立夥伴關係，以產生真實世界證據並傳播最佳實踐通訊協定。針對門診手術中心、醫院和專科診所量身訂做價值提案，可以解決特定場景下的優先事項，例如吞吐量、復健時間表和門診導管管理。透過整合臨床、營運和商業性舉措，產業參與者可以打造引人注目的差異化產品，支援在各種醫療環境中永續應用。

一種透明的調查方法，解釋瞭如何將臨床醫生訪談、臨床指導綜合和比較產品分析結合起來，產生可行的見解

本研究整合了同行評審的臨床文獻、操作指南以及對麻醉師、手術全期護理師和採購專業人員的初步定性訪談，旨在全面了解器械應用的促進因素和障礙。調查方法強調臨床實務洞察、產品特性評估和分銷管道分析之間的三角關係，以確保結論既能反映實證醫學，又能反映日常營運的實際情況。

原始資料收集包括結構化訪談和主題分析，以了解臨床醫生對導管類型、引導技術和門診管理的偏好。二級資訊來源包括近期的程序指南，其中介紹了感染預防和導管固定的最佳實踐，以及有關設備安全性的資訊。在整個過程中，我們注意捕捉門診中心、醫院和專科診所之間的差異，以確保研究結果適用於主要的最終使用者環境。

此分析方法透過比較設備組合和區域市場動態，將定性綜合與特徵映射結合。透過情境分析評估了供應鏈和政策影響，該分析考慮了常見的採購回應和製造商的緩解措施。結果優先考慮可操作的洞察而非抽象的模型，並提供了營運和臨床領導者可以實施的建議，以最佳化採用率和患者療效。

簡潔、前瞻性的結論整合了臨床重點、操作現實和支持有效採用持續周邊神經阻斷導管的協作策略

總而言之，持續性周邊神經阻斷導管在現代疼痛管理策略中發揮著至關重要的作用，其應用受到臨床需求、影像技術進步和醫療服務模式演變等因素的影響。支援超音波整合、安全固定和門診管理的設備特性始終與門診手術中心、醫院和專科診所相關人員的優先事項保持一致。同時，持續投資臨床醫生培訓和證據產生仍然是維持應用和提高操作一致性的關鍵。

包括供應鏈韌性和政策變化在內的商業力量要求製造商和採購團隊協同應對，以維持患者可及性並維護基於價值的醫療目標。將產品創新與強大的培訓、服務支援和自適應供應策略相結合的製造商將最有能力滿足多樣化醫療環境的複雜需求。最終，臨床領導者、產業夥伴和機構負責人之間的持續合作將決定持續周邊神經阻斷導管在促進病患復原的同時，如何有效地實現品質和效率目標。

目錄

第1章：前言

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 導管材料創新，採用抗菌塗層，最大程度降低長期周邊神經阻斷使用過程中的感染風險
  • 人們對超音波導引周邊神經阻斷導管的需求日益成長，以提高整形外科手術的準確性和安全性。
  • 擴大採用整合智慧型手機導管控制的數位輸液泵，以增強病患監測
  • 持續性神經阻斷導管中緩釋性局部麻醉劑劑的出現延長了鎮痛時間並減少了鴉片類藥物的消費量。
  • 開發門診輸液系統，使門診病人能夠持續進行周邊神經阻斷治療並加速康復
  • 生物可吸收導管技術的進步使得止痛藥給藥後導管自行分解
  • 採用即時壓力感測導管檢測導管移位和阻斷失敗
  • 開發可同時輸注鎮痛藥和抗發炎藥物的多腔導管
  • 加強麻醉科和整形外科之間的合作，以標準化連續神經阻斷通訊協定
  • 擴大持續性周邊神經阻斷導管安全和品質標準的法規結構

第6章：2025年美國關稅的累積影響

第7章：人工智慧的累積影響，2025年

8. 持續性周邊神經阻斷導管市場（按類型）

  • 無刺激性導管
  • 刺激導管

9.持續性周邊神經阻斷導管市場引導技術

  • 盲法
  • 神經刺激誘導
  • 超音波引導

第 10 章。 持續性周邊神經阻斷導管市場（依最終用戶）

  • 門診手術中心
  • 醫院
  • 專科診所

第11章。 連續周邊神經阻斷導管市場（依應用）

  • 產科鎮痛
    • 剖腹產
    • 分娩疼痛管理
  • 整形外科
    • 髖關節置換術
    • 膝關節關節重建
    • 肩部手術
  • 術後疼痛管理

12. 持續性周邊神經阻斷導管市場（按地區）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章 持續性周邊神經阻斷導管市場（依類別）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 持續性周邊神經阻斷導管市場（依國家）

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章競爭格局

  • 2024年市佔率分析
  • 2024年FPNV定位矩陣
  • 競爭分析
    • Avanos Medical, Inc.
    • B. Braun Melsungen AG
    • Dyna Medical Corporation
    • Epimed International Inc.
    • ICU Medical, Inc.
    • Lepu Medical Technology（Beijing）Co., Ltd.
    • Medline Industries, LP
    • Medtronic plc
    • Merit Medical Systems, Inc.
    • Nipro Corporation
    • Owens & Minor, Inc.
    • PAJUNK GmbH Medizintechnologie
    • Poly Medicure Ltd.
    • Shunmei
    • Teleflex Incorporated
    • Vygon SA
Product Code: MRR-976C0ED91CFF

The Continuous Peripheral Nerve Block Catheter Market is projected to grow by USD 636.01 million at a CAGR of 5.84% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 403.61 million
Estimated Year [2025] USD 426.18 million
Forecast Year [2032] USD 636.01 million
CAGR (%) 5.84%

An authoritative introduction describing the evolving clinical, operational, and procurement drivers shaping continuous peripheral nerve block catheter adoption in modern care pathways

Continuous peripheral nerve block catheters have become a focal point in perioperative pain management, offering targeted analgesia that reduces systemic opioid reliance and enhances patient recovery. Over recent years, clinicians and procurement teams alike have scrutinized device characteristics such as catheter design, guidance technology compatibility, and ease of integration into multimodal analgesia protocols. These factors have driven an evolution in how healthcare organizations evaluate and adopt continuous nerve block solutions, with attention shifting from single-procedure utility toward broader perioperative pathways that emphasize reduced length of stay and improved functional recovery.

In parallel, clinical practice has increasingly favored technologies that align with enhanced recovery after surgery principles and ambulatory surgical care models. This trend has raised new expectations for device performance, including consistent block efficacy, secure fixation methods that permit early mobilization, and user interfaces that minimize procedure time. As a result, manufacturers and clinical leaders are forging closer collaborations to refine training, standardize protocols, and validate real-world outcomes, creating an environment where technological innovation and clinical evidence jointly influence purchasing and adoption decisions.

Consequently, stakeholders require clear, evidence-driven intelligence that synthesizes device design considerations, guidance technology implications, and end-user perspectives to inform procurement, clinician education, and value-based purchasing strategies. This report seeks to deliver that actionable intelligence by examining market dynamics, clinical adoption patterns, and practical recommendations for integrating continuous peripheral nerve block catheters into contemporary care pathways.

A comprehensive assessment of how clinical priorities, imaging guidance advances, and care delivery changes are converging to redefine device development and adoption dynamics

The landscape for continuous peripheral nerve block catheters is undergoing transformative shifts driven by clinical priorities, technology convergence, and changes in care delivery. Clinically, there is a pronounced move toward opioid-sparing strategies and enhanced recovery protocols, which elevates the importance of reliable regional anesthesia techniques. This clinical imperative has amplified demand for devices that deliver predictable analgesia while enabling early physiotherapy and same-day discharge where appropriate.

Technologically, the convergence of imaging guidance and catheter design is reshaping procedural workflows. Ultrasound guidance has emerged as a preferred modality in many settings because it improves visualization of nerve structures and local anesthetic spread, thereby enhancing block accuracy and safety. Simultaneously, manufacturers are optimizing catheter materials and fixation systems to reduce dislodgement and infection risk, which addresses key practical barriers encountered in ambulatory and inpatient environments. These technological advancements are complemented by improved training tools and simulation-based education that accelerate clinician competency and adoption.

Operational shifts in healthcare delivery also influence the trajectory of adoption. The growth of ambulatory surgical centers and shared-care models places a premium on devices that support streamlined procedures and consistent outcomes across disparate settings. In addition, evolving reimbursement frameworks and quality metrics emphasize patient-reported outcomes and reductions in opioid-related adverse events, creating incentives for hospitals and clinics to prioritize regional anesthesia solutions. Taken together, these clinical, technological, and operational forces are redirecting development priorities and commercial strategies across the value chain.

An analytical overview of the operational and procurement implications stemming from 2025 tariff changes and how supply chain adjustments are reshaping commercial strategies

The introduction of tariff policies in 2025 has introduced a new layer of complexity for procurement, supply chain management, and commercial strategy within the medical device sector. Tariff adjustments influence cost structures across manufacturing, distribution, and procurement channels, requiring stakeholders to reassess sourcing strategies and margin expectations. For manufacturers that rely on cross-border supply chains, these changes have triggered a review of supplier contracts, component localization, and inventory buffers to mitigate exposure to variable import duties and broaden resilience.

Hospitals and ambulatory centers respond to altered cost dynamics by tightening procurement specifications, extending tender cycles, and prioritizing devices that demonstrate not only clinical value but also predictable total cost of ownership. In some cases, purchasers explore alternative supplier relationships or consolidated purchasing agreements to offset additional tariff-induced costs. Meanwhile, smaller specialty clinics may face greater sensitivity to price changes, prompting clinicians to evaluate procedural workflows and device utilization to preserve access to regional anesthesia techniques without eroding clinical quality.

In response, manufacturers and distributors are exploring adaptive strategies such as nearshoring select production, redesigning packaging to reduce tariff exposure, and offering bundled service models that emphasize training, warranty, and consumable management. These approaches aim to preserve competitiveness while maintaining the clinical performance and support services that clinicians expect. The net effect of tariff changes is therefore not only financial but operational, compelling stakeholders to pursue pragmatic adjustments that sustain clinical access and long-term supplier partnerships.

An integrated segmentation analysis explaining how catheter type, imaging and guidance methods, clinical setting, and procedural application jointly determine procurement and adoption decisions

Insight into segmentation reveals how device selection and clinical deployment vary across product type, guidance technology, end-user setting, and application, each shaping distinct adoption pathways. When devices are differentiated by catheter type, considerations center on the intended procedural use and clinician preference for either nonstimulating catheters that simplify insertion or stimulating catheters that provide nerve localization feedback during placement. This distinction influences training requirements and procedural protocols because stimulating catheters may be favored in settings where electrical confirmation of nerve proximity is integrated into clinical practice.

Guidance technology further stratifies clinical workflows and device compatibility. Blind techniques continue to persist in certain resource-constrained environments, but nerve stimulator-guided approaches offer incremental confidence through motor response confirmation. Ultrasound guidance, by contrast, has redefined standards of practice in many centers by providing direct visualization of anatomy, which improves block accuracy and reduces reliance on secondary localization methods. As a result, device features that facilitate ultrasound visualization, such as echogenic catheter design and compatible insertion kits, resonate strongly with teams prioritizing image-guided regional anesthesia.

End-user environments also affect procurement and utilization patterns. Ambulatory surgical centers prioritize rapid turnover, minimal opioid-related complications, and devices that streamline same-day discharge. Hospitals often balance a broader case mix and invest in clinician training and multidisciplinary pathways that support continuous catheter programs across orthopedic and obstetric services. Specialty clinics concentrate on procedure-specific workflows and may adopt devices that align with focused clinical protocols and patient throughput demands.

Applications provide a final lens through which clinicians assess catheter solutions. Obstetric analgesia requires devices and protocols suited for both cesarean delivery and labor pain management, with emphasis on maternal mobility and neonatal safety. Orthopedic surgery presents diverse needs across hip, knee, and shoulder procedures, with pain control strategies that facilitate early mobilization and rehabilitation. Postoperative pain management beyond the operating theater demands secure catheter fixation, infection prevention measures, and clear outpatient protocols to support home-based analgesia when indicated. Taken together, these segmentation perspectives reveal why device portfolios and go-to-market approaches must align tightly with clinical workflows and setting-specific priorities.

A nuanced regional perspective illustrating how infrastructure, reimbursement, and practice variation across the Americas, EMEA, and Asia-Pacific influence device adoption and commercialization strategies

Regional dynamics exert a powerful influence on device selection, clinical training models, and distribution strategies, shaped by differences in healthcare infrastructure, reimbursement practices, and clinical practice patterns. In the Americas, clinical emphasis on enhanced recovery, orthopedic volume, and obstetric services drives interest in devices that support accelerated rehabilitation and strong safety profiles. Urban tertiary centers emphasize advanced imaging integration and multidisciplinary pathways, while ambulatory sites prioritize devices that minimize procedure time and support same-day discharge.

Across Europe, the Middle East, and Africa, heterogeneity in healthcare systems creates diverse adoption environments. High-resource hospitals in Western Europe typically adopt ultrasound-guided regional anesthesia widely, investing in simulation-based clinician training and standardized protocols. Meanwhile, in some parts of the Middle East and Africa, variability in access to imaging equipment and trained personnel leads to continued use of alternative guidance strategies and greater sensitivity to device cost and durability. Distribution networks and regulatory pathways also differ across this broad region, influencing how manufacturers structure market entry and support services.

In the Asia-Pacific region, rapid growth of surgical volumes and expanding ambulatory care capacity drive demand for solutions that can scale across high-throughput settings. Training programs and partnerships with academic centers accelerate adoption of image-guided techniques in many markets, while localized manufacturing and supply arrangements often influence procurement decisions. Across these regions, stakeholders respond to both global clinical trends and region-specific constraints, prompting manufacturers to tailor commercial models, educational outreach, and service offerings to local needs while maintaining consistent device performance standards.

A strategic evaluation of how product innovation, clinician education, and service models converge to define competitive advantage and influence procurement choices in regional anesthesia

Competitive dynamics in the continuous peripheral nerve block catheter space center on product innovation, clinical support services, and the ability to demonstrate consistent performance in real-world settings. Leading manufacturers differentiate through catheter materials and fixation systems designed to reduce dislodgement and infection risk, as well as through accessory kits that simplify sterile technique and ultrasound integration. Equally important are training programs, simulation tools, and clinical partnerships that accelerate adoption by improving clinician confidence and procedural consistency.

Distribution and service models also underpin competitive positioning. Firms that offer bundled solutions combining devices, clinician education, and post-market surveillance gain traction with hospital systems seeking predictable outcomes and reduced operational burden. Strategic collaborations with imaging equipment providers, anesthesiology societies, and academic centers amplify visibility and support guideline-aligned practice adoption. Vendors that maintain responsive supply chains and localized technical support tend to perform better in markets where hospitals prioritize service continuity and rapid device replenishment.

Finally, companies that invest in evidence generation through registries, observational studies, and pragmatic clinical collaborations help to validate real-world effectiveness and inform best practices. This clinical evidence, when paired with robust training and service ecosystems, reinforces trust among clinician champions and purchasing committees, creating a durable competitive advantage that extends beyond product specifications alone.

Actionable recommendations for manufacturers and healthcare leaders to align product development, clinician training, and supply strategies with real-world clinical and operational priorities

Industry leaders can act decisively to capture clinical and commercial opportunities by aligning R&D priorities with end-user workflows and by strengthening clinical support capabilities. Prioritizing catheter features that enhance ultrasound visualization, secure fixation, and infection control will address the practical pain points most commonly cited by clinicians. In parallel, investing in scalable training programs and simulation tools will reduce variability in technique and accelerate adoption, particularly in hospitals and ambulatory centers seeking operator consistency.

Operationally, manufacturers should consider supply chain strategies that reduce exposure to tariff variability and improve responsiveness to regional demand fluctuations. Options include selectively nearshoring high-volume production, developing modular packaging to mitigate tariff thresholds, and formalizing service-level agreements that assure timely replenishment. Commercial teams should emphasize bundled offerings that link device procurement with clinician education, warranty support, and data collection options to quantify procedural outcomes and patient experience.

From a market engagement perspective, leaders should cultivate partnerships with orthopedic and obstetric clinical champions to generate real-world evidence and disseminate best-practice protocols. Tailored value propositions for ambulatory surgical centers, hospitals, and specialty clinics will help address setting-specific priorities such as throughput, rehabilitation timelines, and outpatient catheter management. By integrating clinical, operational, and commercial initiatives, industry players can create compelling, differentiated offerings that support sustainable adoption across diverse care settings.

A transparent research methodology describing how primary clinician interviews, clinical guidance synthesis, and comparative product analysis were integrated to produce actionable insights

This research synthesizes peer-reviewed clinical literature, procedural guidelines, and primary qualitative interviews with anesthesiologists, perioperative nurses, and procurement specialists to develop a comprehensive understanding of device adoption drivers and barriers. The methodology emphasizes triangulation between clinical practice insights, product feature evaluations, and distribution channel analysis to ensure that conclusions reflect both evidence-based medicine and day-to-day operational realities.

Primary data collection included structured interviews and thematic analysis designed to capture clinician preferences around catheter type, guidance technology, and outpatient management. Secondary sources included recent procedural guidelines and device safety communications that inform best practices for infection prevention and catheter fixation. Throughout the process, attention focused on capturing heterogeneity across ambulatory centers, hospitals, and specialty clinics to ensure findings remain applicable across the primary end-user environments.

Analytical methods combined qualitative synthesis with comparative feature mapping across device portfolios and regional market dynamics. Supply chain and policy impacts were assessed through scenario analysis that considered common procurement responses and manufacturer mitigations. The resulting approach prioritizes actionable insight over abstract modeling, delivering recommendations that operational and clinical leaders can implement to optimize adoption and patient outcomes.

A concise and forward-looking conclusion that synthesizes clinical priorities, operational realities, and collaborative strategies underpinning effective adoption of continuous peripheral nerve block catheters

In conclusion, continuous peripheral nerve block catheters occupy a pivotal role in contemporary pain management strategies, with adoption shaped by a confluence of clinical imperatives, imaging technology advances, and evolving care delivery models. Device characteristics that support ultrasound integration, secure fixation, and outpatient management consistently align with stakeholder priorities across ambulatory surgical centers, hospitals, and specialty clinics. Meanwhile, ongoing investments in clinician training and evidence generation remain central to sustaining adoption and improving procedural consistency.

Operational forces, including supply chain resilience and policy shifts, require coordinated responses from manufacturers and procurement teams to preserve access and maintain value-based care objectives. Manufacturers that couple product innovation with robust training, service support, and adaptive supply strategies will be best positioned to meet the complex needs of diverse healthcare settings. Ultimately, sustained collaboration between clinical leaders, industry partners, and institutional purchasers will determine how effectively continuous peripheral nerve block catheters enhance patient recovery while advancing quality and efficiency objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Innovation in catheter materials with antimicrobial coatings to minimize infection risk in prolonged peripheral nerve block use
  • 5.2. Rising demand for ultrasound-guided peripheral nerve block catheters to improve procedural accuracy and safety in orthopedic surgeries
  • 5.3. Increasing adoption of digital infusion pumps integrated with smartphone-enabled catheter control for enhanced patient monitoring
  • 5.4. Emergence of extended-release local anesthetic formulations in continuous nerve block catheters to prolong analgesia and reduce opioid consumption
  • 5.5. Development of ambulatory infusion systems enabling outpatient continuous peripheral nerve block therapy for accelerated rehabilitation
  • 5.6. Advances in bioresorbable catheter technology for automatic degradation after analgesia delivery
  • 5.7. Adoption of real-time pressure-sensing catheters to detect catheter migration or block failure
  • 5.8. Development of multi-lumen catheters enabling simultaneous infusion of analgesic and anti-inflammatory agents
  • 5.9. Increasing collaboration between anesthesiology and orthopedics to standardize continuous nerve block protocols
  • 5.10. Expansion of regulatory frameworks for continuous peripheral nerve block catheter safety and quality standards

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Continuous Peripheral Nerve Block Catheter Market, by Type

  • 8.1. Non Stimulating Catheter
  • 8.2. Stimulating Catheter

9. Continuous Peripheral Nerve Block Catheter Market, by Guidance Technology

  • 9.1. Blind Technique
  • 9.2. Nerve Stimulator Guided
  • 9.3. Ultrasound Guided

10. Continuous Peripheral Nerve Block Catheter Market, by End User

  • 10.1. Ambulatory Surgical Centers
  • 10.2. Hospitals
  • 10.3. Specialty Clinics

11. Continuous Peripheral Nerve Block Catheter Market, by Application

  • 11.1. Obstetric Analgesia
    • 11.1.1. C Section
    • 11.1.2. Labor Pain Management
  • 11.2. Orthopedic Surgery
    • 11.2.1. Hip Replacement
    • 11.2.2. Knee Replacement
    • 11.2.3. Shoulder Surgery
  • 11.3. Postoperative Pain Management

12. Continuous Peripheral Nerve Block Catheter Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Continuous Peripheral Nerve Block Catheter Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Continuous Peripheral Nerve Block Catheter Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Analysis
    • 15.3.1. Avanos Medical, Inc.
    • 15.3.2. B. Braun Melsungen AG
    • 15.3.3. Dyna Medical Corporation
    • 15.3.4. Epimed International Inc.
    • 15.3.5. ICU Medical, Inc.
    • 15.3.6. Lepu Medical Technology (Beijing) Co., Ltd.
    • 15.3.7. Medline Industries, LP
    • 15.3.8. Medtronic plc
    • 15.3.9. Merit Medical Systems, Inc.
    • 15.3.10. Nipro Corporation
    • 15.3.11. Owens & Minor, Inc.
    • 15.3.12. PAJUNK GmbH Medizintechnologie
    • 15.3.13. Poly Medicure Ltd.
    • 15.3.14. Shunmei
    • 15.3.15. Teleflex Incorporated
    • 15.3.16. Vygon SA

LIST OF FIGURES

  • FIGURE 1. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. BRICS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. G7 CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. NATO CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 28. CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NON STIMULATING CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY STIMULATING CATHETER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY BLIND TECHNIQUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY NERVE STIMULATOR GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ULTRASOUND GUIDED, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY C SECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY LABOR PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY HIP REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY KNEE REPLACEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SHOULDER SURGERY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY POSTOPERATIVE PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 116. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 117. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 118. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 119. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 120. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 121. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 123. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 124. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 125. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 126. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 127. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 128. AMERICAS CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 132. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 134. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 136. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 140. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 142. NORTH AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 146. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 148. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 150. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 154. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 156. LATIN AMERICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 165. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 168. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 169. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 170. EUROPE, MIDDLE EAST & AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 171. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 172. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 173. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 174. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 186. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 190. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 192. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 196. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 198. MIDDLE EAST CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 199. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 202. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 203. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 204. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 205. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 206. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 207. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 210. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 211. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 212. AFRICA CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 216. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 217. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 218. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 219. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 221. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 224. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 225. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 226. ASIA-PACIFIC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 229. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 230. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 231. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 232. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 233. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 234. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 235. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 236. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 237. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 238. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 239. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 240. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 241. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 242. ASEAN CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 243. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 244. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 245. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 246. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 247. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 248. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 249. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 250. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 251. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2018-2024 (USD MILLION)
  • TABLE 254. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY OBSTETRIC ANALGESIA, 2025-2032 (USD MILLION)
  • TABLE 255. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2018-2024 (USD MILLION)
  • TABLE 256. GCC CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY ORTHOPEDIC SURGERY, 2025-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 258. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY TYPE, 2025-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 262. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY GUIDANCE TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. EUROPEAN UNION CONTINUOUS PERIPHERAL NERVE BLOCK CATHETER MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)

TABLE 2